Table 4.
PONV | Groups
|
p-values | |||||
---|---|---|---|---|---|---|---|
S
|
R
|
RD
|
|||||
n (%) | |||||||
0 | 23 (100) | 24 (100) | 20 (95.24) | 0.321 | – | – | – |
1 | 0 (0) | 0 (0) | 0 (0) | – | – | – | – |
2 | 0 (0) | 0 (0) | 0 (0) | – | – | – | – |
3 | 0 (0) | 0 (0) | 1 (4.76) | – | – | – | – |
Incidence chronic pain | 10 (47.6) | 7 (29.2) | 4 (19.0) | 0.015* | p1 = 0.167 | p2 = 0.050 | p3 = 0.332 |
Notes: p1, group R vs group S; p2, group RD vs group S; p3, group RD vs group R.
Statistically significant differences (p < 0.05). S, saline; R, 0.5% ropivacaine; RD, 5 mg dexamethasone and 0.5% ropivacaine.
Abbreviation: PONV, postoperative nausea and vomiting.